Li, X. et al. 2025. Research Progress on the CDK4/6 Signaling Pathway and Clinical Application of Its Inhibitors in HR+/HER2- Breast Cancer. Health Nexus: Interdisciplinary Medical Research Journal. 1, (Nov. 2025), 31–37. DOI:https://doi.org/10.63802/healthnexus.V1.2025.148.